Journal Article (Other) DZNE-2026-00815

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Lecanemab in Frühstadien der Alzheimer-Krankheit | Lecanemab in early stages of Alzheimer’s disease

 ;  ;  ;

2025
Springer Medizin Verlag GmbH, ein Teil von Springer Nature Heidelberg

DGNeurologie 8(4), 299 - 301 () [10.1007/s42451-025-00769-1]

This record in other databases:  

Please use a persistent id in citations: doi:

Classification:

Contributing Institute(s):
  1. Clinical Research (Munich) (Clinical Research (Munich))
  2. Clinical Neurodegeneration (AG Levin)
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Database coverage:
DEAL Springer ; DEAL Springer
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > M DZNE > M DZNE-Clinical Research (Munich)
Document types > Articles > Journal Article
Institute Collections > M DZNE > M DZNE-AG Levin
Public records
Publications Database

 Record created 2026-07-24, last modified 2026-07-30


Fulltext:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)